Larimar Therapeutics's total assets for Q3 2025 were $187.35M, an increase of 24.91% from the previous quarter. LRMR total liabilities were $48.31M for the fiscal quarter, a 60.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.